Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Fendler, Wojciech  [Clear All Filters]
2023
Mikulski D, Nowicki M, Dróźdż I, Misiewicz M, Kościelny KPiotr, Okoński K, Krawiec K, Perdas E, Wierzbowska A, Fendler W. High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation. Front Oncol. 2023;13:1250355.
Kościelny K, Mikulski D, Nowicki M, Wyka K, Misiewicz M, Perdas E, Wierzbowska A, Fendler W. A low thrombospondin-1 serum concentration is related to increased bacteremia risk in lymphoma patients treated with BeEAM/BEAM conditioning regimen and autologous stem cell transplantation. Transpl Infect Dis. 2023:e14212.
Nowicka Z, Tomasik B, Kozono D, Stawiski K, Johnson T, Haas-Kogan D, Ussowicz M, Chowdhury D, Fendler W. Serum miRNA-based signature indicates radiation exposure and dose in humans: a multicenter diagnostic biomarker study. Radiother Oncol. 2023:109731.
2022
Mikulski D, Kościelny K, Nowicki M, Wawrzyniak E, Kalwas M, Kowalik M, Pryt M, Sęczkowska E, Świątek A, Wierzbowska A, et al. Neutrophil to lymphocyte ratio (NLR) impact on the progression-free survival and overall survival of multiple myeloma patients treated with high-dose chemotherapy and autologous stem cell transplantation. Leuk Lymphoma. 2022:1-9.
2019
Fidyt K, Pastorczak A, Goral A, Szczygiel K, Fendler W, Muchowicz A, Bartlomiejczyk MAdam, Madzio J, Cyran J, Graczyk-Jarzynka A, et al. Targeting the thioredoxin system as a novel strategy against B cell acute lymphoblastic leukemia. Mol Oncol. 2019.